AcelRX Pharmaceuticals【ACRX】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.86

買値

0.861

売値

0.89

出来高

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

14.579M

前日終値

0.86

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

発行済株式数

16,952,000

配当利回り

PER

-0.67

1 株当たり利益 (EPS)

-1.09

歳入

651k

純利益

-18.4M

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-... AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

talphera.com

本社

Wilmington, Delaware, USA

設立

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ACRX - Frequently Asked Questions (FAQ)

What is the current AcelRX Pharmaceuticals share price?

The current share price of AcelRX Pharmaceuticals is US$ 0.86

How many AcelRX Pharmaceuticals shares are in issue?

AcelRX Pharmaceuticals has 16,952,000 shares in issue

What is the market cap of AcelRX Pharmaceuticals?

The market capitalisation of AcelRX Pharmaceuticals is USD 14.58M

What is the 1 year trading range for AcelRX Pharmaceuticals share price?

AcelRX Pharmaceuticals has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of AcelRX Pharmaceuticals?

The price to earnings ratio of AcelRX Pharmaceuticals is -0.67

What is the cash to sales ratio of AcelRX Pharmaceuticals?

The cash to sales ratio of AcelRX Pharmaceuticals is 19.01

What is the reporting currency for AcelRX Pharmaceuticals?

AcelRX Pharmaceuticals reports financial results in USD

What is the latest annual turnover for AcelRX Pharmaceuticals?

The latest annual turnover of AcelRX Pharmaceuticals is USD 651k

What is the latest annual profit for AcelRX Pharmaceuticals?

The latest annual profit of AcelRX Pharmaceuticals is USD -18.4M

What is the registered address of AcelRX Pharmaceuticals?

The registered address for AcelRX Pharmaceuticals is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808

What is the AcelRX Pharmaceuticals website address?

The website address for AcelRX Pharmaceuticals is talphera.com

Which industry sector does AcelRX Pharmaceuticals operate in?

AcelRX Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
SLXNSilexion Therapeutics Corporation	US$ 1.14 (96.55%)	169.93M
RNAZTransCode Therapeutics Inc	US$ 11.79 (72.62%)	15.18M
RFACRF Acquisition Corporation	US$ 8.11 (62.20%)	5.77k
YIBOPlanet Image International Ltd	US$ 4.98 (61.69%)	47.84M
BACKIMAC Holdings Inc	US$ 1.1702 (41.16%)	52.14M
LPTXLeap Therapeutics Inc	US$ 0.6501 (-71.11%)	7.48M
STSSSharps Technology Inc	US$ 0.4454 (-69.49%)	11.19M
SABSSAB Biotherapeutics Inc	US$ 2.2568 (-48.24%)	905.32k
MGOLMGO Global Inc	US$ 0.1754 (-38.02%)	13.85M
INKTMiNK Therapeutics Inc	US$ 5.89 (-33.36%)	53.66k
HEPAHepion Pharmaceuticals Inc	US$ 0.2224 (34.79%)	229.36M
NVDANVIDIA Corporation	US$ 121.0425 (2.21%)	226.93M
SLXNSilexion Therapeutics Corporation	US$ 1.14 (96.55%)	169.93M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.4766 (15.65%)	118.47M
TRIBTrinity Biotech PLC	US$ 1.06 (39.47%)	98.18M